Total Payments
$1,955
2024 Payments
$537.91
Companies
22
Transactions
74
Medicare Patients
1,422
Medicare Billing
$91,218
Payment Breakdown by Category
Food & Beverage$1,955 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,955 | 74 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $358.13 | 23 | $0 (2024) |
| GRT US Holding, Inc. | $284.96 | 1 | $0 (2022) |
| AngioDynamics, Inc. | $216.85 | 3 | $0 (2023) |
| Boston Scientific Corporation | $159.78 | 2 | $0 (2024) |
| Lilly USA, LLC | $152.86 | 9 | $0 (2024) |
| Medtronic, Inc. | $119.05 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $115.76 | 7 | $0 (2024) |
| Novo Nordisk Inc | $97.02 | 6 | $0 (2024) |
| BIOTRONIK INC. | $76.93 | 1 | $0 (2023) |
| Averitas Pharma Inc. | $57.62 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $537.91 | 23 | Medtronic, Inc. ($119.05) |
| 2023 | $726.13 | 21 | AngioDynamics, Inc. ($216.85) |
| 2022 | $626.00 | 27 | GRT US Holding, Inc. ($284.96) |
| 2021 | $64.81 | 3 | AbbVie Inc. ($25.94) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/07/2024 | Medtronic, Inc. | INCEPTIV (Device) | Food and Beverage | In-kind items and services | $119.05 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/02/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $33.36 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Respiratory | ||||||
| 09/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $21.12 | General |
| Category: Cardiovascular Device | ||||||
| 08/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: PAIN | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Respiratory | ||||||
| 08/15/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: General - Pain Management_NMD | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: RESPIRATORY | ||||||
| 06/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Hematology | ||||||
| 05/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Respiratory | ||||||
| 04/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: RESPIRATORY | ||||||
| 02/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Diabetes | ||||||
| 11/17/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes | ||||||
| 10/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 968 | 1,433 | $365,661 | $57,215 |
| 2022 | 8 | 309 | 458 | $86,566 | $18,599 |
| 2021 | 4 | 145 | 193 | $35,253 | $15,404 |
Total Patients
1,422
Total Services
2,084
Medicare Billing
$91,218
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 252 | $128,613 | $22,406 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 187 | $67,193 | $10,612 | 15.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 73 | 73 | $37,945 | $9,105 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 103 | 103 | $68,102 | $6,316 | 9.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 87 | 87 | $38,427 | $3,256 | 8.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 24 | 24 | $6,882 | $1,819 | 26.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 218 | 490 | $9,041 | $1,007 | 11.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $1,586 | $715.44 | 45.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 53 | 61 | $732.00 | $512.40 | 70.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 12 | 12 | $1,986 | $486.60 | 24.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 26 | $1,507 | $277.75 | 18.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 25 | $971.00 | $238.00 | 24.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 13 | 13 | $860.60 | $210.86 | 24.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 26 | $1,464 | $184.96 | 12.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 24 | 30 | $351.60 | $66.00 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 113 | $34,122 | $7,028 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $18,143 | $3,154 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 49 | $10,635 | $2,668 | 25.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $11,461 | $2,234 | 19.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 13 | 13 | $6,469 | $1,645 | 25.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 35 | 42 | $2,520 | $1,248 | 49.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 63 | 164 | $3,026 | $574.40 | 19.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 14 | 16 | $190.00 | $47.10 | 24.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 87 | 131 | $28,296 | $12,890 | 45.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,597 | $1,215 | 33.8% |
About Dr. Robert Claflin, DO
Dr. Robert Claflin, DO is a Sports Medicine healthcare provider based in Mesa, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2017. The National Provider Identifier (NPI) number assigned to this provider is 1164959441.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Claflin, DO has received a total of $1,955 in payments from pharmaceutical and medical device companies, with $537.91 received in 2024. These payments were reported across 74 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,955).
As a Medicare-enrolled provider, Claflin has provided services to 1,422 Medicare beneficiaries, totaling 2,084 services with total Medicare billing of $91,218. Data is available for 3 years (2021–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Family Medicine
- Location Mesa, AZ
- Active Since 05/17/2017
- Last Updated 07/11/2022
- Taxonomy Code 207QS0010X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164959441
Products in Payments
- Qutenza (Drug) $284.96
- AURYON LASER SYSTEM 100-120 VAC (Device) $216.85
- VRAYLAR (Drug) $192.15
- WATCHMAN FLX (Device) $138.78
- MOUNJARO (Drug) $132.66
- UBRELVY (Drug) $125.28
- INCEPTIV (Device) $119.05
- Ozempic (Drug) $97.02
- Pulsar-18 T3 (Device) $76.93
- QUTENZA (Drug) $57.62
- AIRSUPRA (Drug) $52.10
- NURTEC ODT (Drug) $47.57
- FARXIGA (Drug) $42.74
- QULIPTA (Drug) $40.70
- Optimizer (Device) $38.16
- JARDIANCE (Drug) $34.53
- ACCRUFER (Drug) $32.64
- AREXVY (Drug) $31.37
- FREESTYLE LIBRE 3 (Device) $23.52
- BREZTRI (Drug) $20.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Mesa
Dr. Daniel Mullen, M.d, M.D
Sports Medicine — Payments: $62,552
Sports Medicine $62,552
Carl Allred, Md, MD
Sports Medicine — Payments: $14,234
Sports Medicine $14,234
William Durkin, Do, DO
Sports Medicine — Payments: $13,674
Sports Medicine $13,674
Dr. Charles Peterson, M.d, M.D
Sports Medicine — Payments: $5,101
Sports Medicine $5,101
Dr. Thai Vu, Do, DO
Sports Medicine — Payments: $111.34
Sports Medicine $111.34
Stephen Hatfield, D.o, D.O
Sports Medicine — Payments: $47.07
Sports Medicine $47.07